Omvoh 00002-8870-27
Generic: Mirikizumab-Mrkz
- Manufacturer
- Eli Lilly And Company
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- April 29, 2024
- Listing Expires
- December 31, 2026
- Application
- BLA761279
Need to source Omvoh? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Mirikizumab | 100 mg/mL |
Drug Class
Interleukin-23 Antagonist [EPC]Interleukin-23 Antagonist [EPC]Interleukin-23 Antagonists [MoA]
Selected Package
00002-8870-27Selected2 SYRINGE in 1 CARTON (0002-8870-27) / 1 mL in 1 SYRINGE (0002-8870-01)